{
  "title": "Mesdopetam",
  "content-preview": "Mesdopetam (INNTooltip International Nonproprietary Name; developmental code names IRL-790, IPN60170) is a dopamine D2 and D3 receptor antagonist with preference for the D3 receptor which is under development for the treatment of Parkinson's disease, drug-induced dyskinesia, and psychotic disorders.",
  "url": "https://en.wikipedia.org/wiki/Mesdopetam",
  "pageid": 77972365,
  "title-terms": {
    "mesdopetam": 1
  },
  "content-terms": {
    "mesdopetam": 11,
    "inntooltip": 2,
    "international": 2,
    "nonproprietary": 2,
    "name": 2,
    "developmental": 1,
    "code": 1,
    "names": 1,
    "irl790": 2,
    "ipn60170": 1,
    "dopamine": 10,
    "d2": 3,
    "d3": 8,
    "receptor": 12,
    "antagonist": 3,
    "preference": 2,
    "development": 4,
    "treatment": 3,
    "parkinsons": 3,
    "disease": 3,
    "druginduced": 2,
    "dyskinesia": 5,
    "psychotic": 2,
    "disorders": 3,
    "described": 3,
    "developers": 1,
    "psychomotor": 1,
    "stabilizing": 1,
    "properties": 2,
    "pharmacology": 1,
    "intention": 1,
    "behind": 1,
    "develop": 1,
    "novel": 2,
    "based": 1,
    "agonist": 1,
    "rather": 1,
    "antagonistlike": 1,
    "structural": 1,
    "motifs": 1,
    "agonistlike": 2,
    "physicochemical": 1,
    "eg": 1,
    "smaller": 1,
    "molecular": 1,
    "size": 1,
    "greater": 1,
    "hydrophilicity": 1,
    "hypothesized": 1,
    "would": 1,
    "result": 1,
    "specific": 1,
    "interactions": 1,
    "similar": 1,
    "agonists": 1,
    "like": 2,
    "without": 2,
    "intrinsic": 1,
    "activity": 2,
    "turn": 1,
    "resulting": 1,
    "different": 1,
    "vivo": 1,
    "effects": 6,
    "conventional": 1,
    "antagonists": 4,
    "specifically": 2,
    "antidyskinetic": 2,
    "antipsychotic": 1,
    "fewer": 1,
    "motor": 1,
    "side": 3,
    "sought": 1,
    "also": 4,
    "extensive": 1,
    "preclinical": 2,
    "research": 1,
    "suggest": 1,
    "reduce": 1,
    "levodopainduced": 3,
    "compromising": 1,
    "antiparkinsonian": 1,
    "levodopa": 1,
    "6": 1,
    "8fold": 1,
    "ki": 3,
    "90": 1,
    "nm": 3,
    "540\u2013750": 1,
    "displays": 1,
    "paradoxical": 1,
    "binding": 1,
    "mode": 1,
    "spite": 1,
    "lack": 1,
    "activational": 1,
    "efficacy": 2,
    "antagonizing": 1,
    "autoreceptors": 1,
    "found": 1,
    "disinhibit": 1,
    "release": 1,
    "prefrontal": 1,
    "cortex": 1,
    "ventral": 1,
    "tegmental": 1,
    "area": 1,
    "striatum": 1,
    "might": 1,
    "involved": 1,
    "possible": 1,
    "therapeutic": 1,
    "benefits": 1,
    "agents": 1,
    "drug": 1,
    "ligand": 1,
    "sigma": 1,
    "\u03c31": 1,
    "870": 1,
    "affinity": 1,
    "certain": 1,
    "serotonin": 2,
    "receptors": 2,
    "including": 1,
    "5ht1a": 1,
    "5ht2a": 1,
    "animals": 1,
    "effect": 1,
    "spontaneous": 1,
    "locomotor": 2,
    "assessed": 1,
    "doses": 1,
    "antagonizes": 1,
    "reduces": 1,
    "dextroamphetamine": 1,
    "dizocilpineinduced": 1,
    "hyperactivity": 1,
    "clinical": 3,
    "trials": 3,
    "reported": 2,
    "include": 1,
    "worsened": 1,
    "parkinsonism": 1,
    "headache": 1,
    "fatigue": 1,
    "asthenia": 1,
    "dissociation": 1,
    "first": 1,
    "literature": 1,
    "2012": 1,
    "september": 1,
    "2024": 1,
    "phase": 4,
    "23": 1,
    "1": 1,
    "psychosis": 1,
    "interest": 1,
    "potential": 1,
    "impulse": 1,
    "control": 1,
    "2019": 1,
    "received": 1,
    "dopetam": 1,
    "suffix": 1,
    "supposedly": 1,
    "representing": 1,
    "new": 1,
    "mechanism": 1,
    "action": 1,
    "among": 1,
    "modulators": 1,
    "2023": 1,
    "failed": 1,
    "meet": 1,
    "primary": 1,
    "endpoint": 1,
    "2b": 1,
    "trial": 2,
    "however": 1,
    "indications": 1,
    "still": 1,
    "seen": 1,
    "3": 1,
    "planned": 1,
    "yet": 1,
    "completed": 1,
    "approved": 1,
    "see": 1,
    "pirepemat": 1,
    "references": 1,
    "external": 1,
    "links": 1,
    "adisinsight": 1,
    "irlab": 1,
    "therapeutics": 1
  },
  "title-length": 1,
  "content-length": 302,
  "curious_frequency": 1,
  "uplifting_frequency": 0,
  "entertaining_frequency": 1,
  "sad_frequency": 3,
  "general_frequency": 0
}